Thomas M. Hitchcock
Cino @Revance
Signup · Get unlimited contacts
WORK HISTORY
Cino @Revance
EDUCATION
Yale School of Medicine
Postdoctorate, Biomedical Engineering
Duke University School of Medicine
Postdoctorate, Biomedical Engineering
Clemson University
PhD, Genetics
ABOUT THOMAS M. HITCHCOCK
Thomas M. Hitchcock, Ph.D. is a holobiontologist, specializing in the skin biome. He earned his PhD in Genetics from Clemson University where he studied DNA damage and repair in both prokaryotic and eukaryotic systems, and went on to complete post-doctoral trainings at Duke University and Yale University in Biomedical Engineering, Vascular Biology and Therapeutics, where he researched use of viral vectors in gene therapy techniques used to improve cardiovascular tissue engineering methodologies. He concluded his academic training at Weil Cornell Medical College studying multiple myeloma genetics. Following his post-doctoral studies, Dr. Hitchcock began working in the field of dermatology at companies such as Ulthera, which sold in 2013 to Merz. In 2013, Dr. Hitchcock helped to found aesthetic device company Bellus Medical (now Crown Aesthetics) and served as the Acting Chief Scientific Officer until the acquisition by Crown Laboratories in 2018. He also Founded the skin microbiome technology company Xycrobe Therapeutics Inc. in 2014 and served as its Chief Executive Officer until acquisition by Crown in 2019. Dr. Hitchcock currently serves as the Chief Science Officer for Crown Laboratories and oversees Clinical Development, Medical Affairs, Biological Sciences (including Microbial Development) and Research & Development for Crown and its subsidiaries. Additionally, Dr. Hitchcock serves as an Adjunct Faculty member at the East Tennessee State University James H. Quillen College of Medicine where he serves to collaborate with the faculty and students on research innovation.As an inventor, Dr. Hitchcock has also been issued patents on his inventions in aesthetic medicine, dermatology and microbiology. His most noteworthy invention is that of the Xycrobe technology, creating a new vertical of skin biome therapeutics. His work has been both presented to the scientific community and published in noteworthy scientific journals. Additionally, he is the co-author of the book “Rebooting the Biome”, along with notable dermatologist Doris Day, M.D.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.